QIAGEN
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.About QGEN
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.
QGEN Key Statistics
Stock Snapshot
As of today, QIAGEN(QGEN) shares are valued at $43.52. The company's market cap stands at 9.01B, with a P/E ratio of 22.02 and a dividend yield of 0.81%.
On 2026-08-28, QIAGEN(QGEN) shares started trading at $43.71, with intraday highs of — and lows of —.
Trading activity shows a volume of 705, compared to an average daily volume of 3.83M.
The stock's 52-week range extends from a low of $32.53 to a high of $57.82.
The stock's 52-week range extends from a low of $32.53 to a high of $57.82.
QGEN News
Qiagen (QGEN) announced the commercial launch of QIAsymphony Connect, an IVD-compliant platform for automated clinical nucleic acid extraction. Building on the...
Qiagen stock has delivered a weak long term result over the past five years, while the valuation checks now send a mixed message as the intrinsic value estimate...
...
Analyst ratings
59%
of 22 ratingsMore QGEN News
Qiagen ( (QGEN) ) just unveiled an announcement. The Netherlands Authority for the Financial Markets has disclosed that Goldman Sachs Group Inc. holds a total...
William Blair analyst Matt Larew has maintained their neutral stance on QGEN stock, giving a Hold rating on August 11. Unlock powerful investing tools with Tip...
(RTTNews) - QIAGEN N.V. (QGEN) announced Monday that Jonathan Pratt has been appointed Chief Executive Officer, effective September 1, 2026. He brings to QIAGEN...
10:01 EDT Qiagen (QGEN) trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>...
QIAGEN (QGEN) announced that Jonathan M. Pratt has been appointed CEO, effective September 1, 2026. Pratt most recently served as President and CEO of Filtratio...
QIAGEN (QGEN) remains focused on delivering solid profitable growth by advancing its growth pillars, improving operating efficiency and allocating capital to th...
In August 2026, QIAGEN announced that the U.S. FDA had cleared its QIAstat-Dx BCID GPF Plus AMR Panel, the first QIAstat-Dx bloodstream infection panel to recei...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.